Hims & Hers Health, Inc. HIMS
Launched in 2017, Hims & Hers Health, Inc. (and together with its subsidiaries, “Hims & Hers”, the “Company”, “we”, “us” or “our”) has built a consumer-first platform transforming the way customers fulfill their health and wellness needs. 10-K, Item 1
- Headquarters
- San Francisco, CA
- CEO
- Andrew Dudum
- Next results
- around Feb 22, 2027
Where each dollar of revenue went, FY2025
Revenue of $2.3B through the costs to a net profit of $128.4M · income statement of the 10-K
HIMS among Health care peers
Six ratios from the latest 10-K. Each corner is the share of 154 peers the company is above, not a score.
What changed
53 new risk paragraphs and 2 accounting facts worth reading about. 10-K filed Feb 23, 2026 against Feb 24, 2025.
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
Accounting checks
11 checks on the latest 10-K. Checks, not verdicts.
2facts worth reading about the other 9 checks found nothing to note
-
Receivables growing faster than revenueReceivables +426.2% ($6.1M to $32.1M) vs revenue +59.0% ($1.5B to $2.3B), +367.2 pts apart
-
Critical audit matters changedNew this year: Assessment of the acquisition date fair value of the platform partnerships intangible asset acquired in a business combination (“As discussed in Note 3 to the consolidated financial statements, in July 2025, the Company acquired all of the outstanding equity of Zava for a purchase price of $258.0 million. The acquisition was accounted for as a business combination using the acquisition method of accounting with the purchase p”). No longer listed: Realizability of domestic deferred tax assets
-
Cash from operations $300.0M vs net income $128.4M (FY ending Dec 31, 2025)
8 more checks with nothing to note
-
Inventory +24.4% ($64.4M to $80.1M) vs revenue +59.0% ($1.5B to $2.3B), -34.6 pts apart
-
Same auditor in both 10-Ks: KPMG LLP
-
No statement of substantial doubt about going concern
-
No 8-K item 4.02 in the last 2 years
-
No NT 10-K or NT 10-Q in the last 2 years
-
No sentence in the 10-K concludes that controls were not effective because of a material weakness
-
No 8-K item 2.06 in the last 2 years
-
No 8-K item 1.03 in the last 2 years
In their words
53 paragraphs in Risk Factors that were not in the 10-K filed Feb 24, 2025. Quoted as filed.
-
Item 1A · new paragraph · not in the 10-K filed Feb 24, 2025 10-K, ITEM 1A
The evolving regulatory landscape has also impacted our ability to continue offering access to such products. For example, in the United States, all doses of semaglutide branded under Ozempic and Wegovy became listed as available on the FDA’s shortage list as of October 30, 2024. On February 21, 2025, the FDA resolved the semaglutide…
-
Item 1A · new paragraph · not in the 10-K filed Feb 24, 2025 10-K, ITEM 1A
Promoting prescription medicines via influencers is strictly prohibited in the United Kingdom, the European Union, and Canada. Regulators have increased scrutiny of social media posts, sponsored content, and discount codes that illegally advertise prescription medicines to the public, particularly for high-profile prescription medicines…
-
Item 1A · new paragraph · not in the 10-K filed Feb 24, 2025 10-K, ITEM 1A
In the United Kingdom, pharmacies, pharmacists, and pharmacy technicians are regulated by the GPhC, which sets standards for the safe and effective provision of pharmacy services, including those provided at a distance (such as online and mail-order pharmacies). Pharmacies must be registered with the GPhC and are subject to regular…
-
Item 1A · new paragraph · not in the 10-K filed Feb 24, 2025 10-K, ITEM 1A
The planned acquisition of Eucalyptus is subject to conditions, some or all of which may not be satisfied or completed on a timely basis, if at all. Completion of the planned acquisition of Eucalyptus (the “Proposed Acquisition”) is subject to the satisfaction or waiver of customary and other closing conditions, including regulatory…
New risk paragraphs, against peers
Latest 10-K of each, Health care companies closest in revenue
Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.
Financial performance
Last 4 fiscal years · 10-K XBRL
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $526.9M | $872.0M | $1.5B | $2.3B |
| Net income | −$65.7M | −$23.5M | $126.0M | $128.4M |
| Operating cash flow | −$26.5M | $73.5M | $251.1M | $300.0M |
| Free cash flow | −$33.7M | $47.0M | $198.3M | $57.4M |
Revenue, FY2019 to FY2025
Ten fiscal years, each from its own 10-K · XBRL · USD
$2.3B ▲ 59.0% in FY2025$128.4M ▲ 1.8% in FY2025$57.4M ▼ 71.0% in FY2025
Recent filings
6 filings in the last 30 days · SEC EDGAR
-
Planned saleNov 9, 2026Irene Becklund (Former Chief Accounting Officer(2)) ended a 10b5-1 trading plan reported in the 10-Q, up to 52,499 shares, runs to Feb 25, 2027
-
Planned saleNov 9, 2026Andrew Dudum (Director and Chief Executive Officer) adopted a 10b5-1 trading plan reported in the 10-Q, up to 2,836,791 shares, runs to Sep 8, 2027
-
8-KNov 9, 2026Quarterly results, Other events 8-K items 2.02, 8.01
-
8-KNov 9, 2026Director or officer change 8-K item 5.02
-
10-QNov 9, 2026Quarterly report (10-Q) period ended Sep 30, 2026
About the company
Hims & Hers Health, Inc., San Francisco, CA · from the 10-K filed Feb 23, 2026
Launched in 2017, Hims & Hers Health, Inc. (and together with its subsidiaries, “Hims & Hers”, the “Company”, “we”, “us” or “our”) has built a consumer-first platform transforming the way customers fulfill their health and wellness needs. We believe that the Company has the technical infrastructure, distributed provider network, and access to clinical capabilities to lead the migration of routine office visits to a personalized, digital, accessible format.
- Headquarters
- San Francisco, CA
- Country
- United States
- Reports in
- USD
- Listed on
- NYSE
- Fiscal year ends
- December 31
- Last results
- Nov 9, 2026
- Incorporated in
- DE
Email alerts
Sources
The 10-K filed Feb 23, 2026 (open at SEC), compared with the 10-K filed Feb 24, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.
Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HIMS/export.csv") into a cell.